Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Alati

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Cancers|January 10, 2026
Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?Caterina Alati, Martina Pitea, Matteo Molica, et al.
Haematologica|February 19, 2011
Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physiciansEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Leukemia & Lymphoma|April 7, 2010
Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of lifeEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Hematology Reports|November 25, 2024
Treatment Strategies Used in Treating Myelofibrosis: State of the ArtMassimo Martino, Martina Pitea, Annalisa Sgarlata, et al.
Cytotherapy|July 20, 2015
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patientsMassimo Martino, Anna Grazia Recchia, Tiziana Moscato, et al.
Hematology Reports|June 25, 2026
Quality of Life in CAR-T Cell TherapyCaterina Alati, Martina Pitea, Gaetana Porto, et al.
European Journal of Haematology|August 22, 2023
Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantationFilippo Antonio Canale, Martina Pitea, Caterina Alati, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2014
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimenRoberta Fedele, Giuseppe Messina, Tiziana Martinello, et al.
International Journal of Molecular Sciences|November 11, 2022
Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonMassimo Martino, Virginia Naso, Barbara Loteta, et al.
Cancers|February 27, 2026
Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision CareCaterina Alati, Matteo Molica, Martina Pitea, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancers|January 10, 2026
Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?Caterina Alati, Martina Pitea, Matteo Molica, et al.
Haematologica|February 19, 2011
Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physiciansEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Leukemia & Lymphoma|April 7, 2010
Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of lifeEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Hematology Reports|November 25, 2024
Treatment Strategies Used in Treating Myelofibrosis: State of the ArtMassimo Martino, Martina Pitea, Annalisa Sgarlata, et al.
Cytotherapy|July 20, 2015
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patientsMassimo Martino, Anna Grazia Recchia, Tiziana Moscato, et al.
Hematology Reports|June 25, 2026
Quality of Life in CAR-T Cell TherapyCaterina Alati, Martina Pitea, Gaetana Porto, et al.
European Journal of Haematology|August 22, 2023
Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantationFilippo Antonio Canale, Martina Pitea, Caterina Alati, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2014
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimenRoberta Fedele, Giuseppe Messina, Tiziana Martinello, et al.
International Journal of Molecular Sciences|November 11, 2022
Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonMassimo Martino, Virginia Naso, Barbara Loteta, et al.
Cancers|February 27, 2026
Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision CareCaterina Alati, Matteo Molica, Martina Pitea, et al.
Pageof 5